2023. Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes: A Narrative Review of Who Needs Fibrosis Staging and When. Journal of Clinical Diabetes and Obesity. 3, 1 (Sep. 2023), 19–24. DOI:https://doi.org/10.5281/zenodo.22258263.